Location: Home
  • search
  • go
  • Relate News
  • 4/19/2025China Issues New Guidelines to Streamline Mainland Registration for Or...
  • 3/20/2025State Council Issues the Opinion on Enhancing TCM Quality and Promotin...
  • 1/12/2025CMS Licensed Dimentia Drug ZUNVEYL from Alpha Cognition
  • 12/3/2024CMS Gains Licenses Class 1 New Drug Targeting Gout and Hyperuricemia f...
  • 11/27/2024CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China
  • 8/15/2024China Introduces Guidelines to Encourage Development of 'Digital, Smar...
  • 4/4/2024Rohto and Mitsui to Buy TCM Company for $590M
  • 4/1/2024CMS and Incyte Enter License Deal for Povorcitinib in China and SE Asi...
  • 2/5/2024CMS Licenses Greater China Rights of First-line Phosphate-lowering Dru...
  • 1/23/2024Chinese TCM Institutions Provided Diagnosis and Treatment to 1.28B Peo...
  • 10/30/2023CDE Solicits Comments on the Technical Guidelines for Stability Study ...
  • 10/24/2023CDE Solicits Comments on the Technical Guidelines for Clinical R&D of ...
  • 10/18/2023CDE Issues the Technical Guidelines for Pharmaceutical Research of New...
  • 8/24/2023CMS Licenses China Rights of Class 1 Anti-Ischemic Stroke New Drug fro...
  • 3/30/2023Rxilient and Junshi form JV to Develop and Commercialize Toripalimab i...
  • 2/14/2023NMPA Issues the Special Rules for TCM Registration
  • 12/22/2022CDE Issues Two New Guidelines for Clinical Evaluation of New TCMs
  • 12/5/2022Incyte Forms Partnership with CMS for Ruxolitinib Cream in Greater Chi...
  • 11/11/2022NMPA Solicits Comments on the Special Rules for TCM Registration
  • 9/27/2022CDE Solicits Comments on Two Draft Guidelines on TCM Registration
  • 5/10/2022NMPA Issues Two Guidelines for TCM Registration and Evaluation
  • 3/11/2022CDE Solicits Comments on Two Draft TCM Registration Guidelines
  • 1/7/2022CDE Issues the Technical Guidance for Research of New TCM Toxicology S...
  • 9/22/2021China-based CMS Joins BaseLaunch as Latest Partner
  • 3/25/2021Shanghai Passes Law to Facilitate Traditional Chinese Medicine
  • 3/12/2021CDE Issues the Guidelines for Acceptance and Evaluation of TCM Changes
  • 2/5/2021CMS Acquires Dermatology Specialty Firm Luqa
  • 1/15/2021CDE Issues the Technical Guidelines for Quality Studies of TCM New Dru...
  • 12/17/2020CDE Issues the Technical Guidelines for Biological Effect Detection St...
  • 11/10/2020CDE Issues the Pharmaceutical Dossiers Requirements for Communication ...
  • Page:1/4 Total number of articles:108: [First][<<] [1] [2] [3] [4] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group